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ABSTRACT
Objective: Antibiotics are prescribed too often in acutely ill children in primary care. We exam-
ined whether a Point-of-Care (POC) C-reactive Protein (CRP) test influences the family physicians’
(FP) prescribing rate and adherence to the Evidence Based Medicine (EBM) practice guidelines.
Design: Cluster randomized controlled trial.
Setting: Primary care, Flanders, Belgium.
Intervention: Half of the children with non-severe acute infections (random allocation of practices to
perform POC CRP or not) and all children at risk for serious infection were tested with POC CRP.
Subjects: Acutely ill children consulting their FP.
Main outcome measure: Immediate antibiotic prescribing.
Results: 2844 infectious episodes recruited by 133 FPs between 15 February 2013 and 28
February 2014 were analyzed. A mixed logistic regression analysis was performed. Compared to
episodes in which CRP was not tested, the mere performing of POC CRP reduced prescribing in
case EBM practice guidelines advise to prescribe antibiotics (adjusted odds ratio (aOR) 0.54 (95%
Confidence Interval (CI) 0.33–0.90). Normal CRP levels reduced antibiotic prescribing, regardless
of whether the advice was to prescribe (aOR 0.24 (95%CI 0.11–0.50) or to withhold (aOR 0.31
(95%CI 0.17–0.57)). Elevated CRP levels did not increase antibiotic prescribing.
Conclusion: Normal CRP levels discourage immediate antibiotic prescribing, even when EBM
practice guidelines advise differently. Most likely, a normal CRP convinces FPs to withhold antibi-
otics when guidelines go against their own gut feeling. Future research should focus on
whether POC CRP can effectively identify children that benefit from antibiotics more accurately,
without increasing the risks of under-prescribing.
KEY POINTS
What is previously known or believed on this topic
 Antibiotics are prescribed too often for non-severe conditions. Point-of-care (POC) C-reactive
Protein (CRP) testing without guidance does not reduce immediate antibiotic prescribing in
acutely ill children in primary care.
What this research adds
 FPs clearly consider CRP once available: normal CRP levels discourage immediate antibiotic
prescribing, even when EBM practice guidelines advise differently. Most likely, a normal CRP
convinces FPs to withhold antibiotics when guidelines go against their own gut feeling.
 Future research should focus on whether POC CRP can effectively identify children that bene-
fit from antibiotics more accurately, without increasing the risks of under-prescribing.
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Introduction
Antibiotics are prescribed too often for acutely ill chil-
dren in primary care [1]. One possible explanation
could be the physicians’ diagnostic uncertainty, as dis-
tinguishing between viral and bacterial infections is
clinically challenging and denying antibiotics to a child
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with a possible bacterial infection feels inappropriate
[2–6]. To promote appropriate prescribing, evidence-
based medicine (EBM) practice guidelines were drawn
up [7]. They inform physicians in which specific clinical
conditions antibiotics should be prescribed. However,
they are not always clear-cut, still leave room for
doubt and subjective assessment (e.g. “severe” pain,
“less” fluid intake).
C-reactive protein (CRP) has recently been put for-
ward as an objective tool to increase diagnostic cer-
tainty. Research has shown that point-of-care (POC)
CRP testing improves antibiotic prescribing rates in
adults with respiratory tract infections in primary care
[8]. In comparable health care settings, no significant
reduction has been found in children [9–11].
Aabenhus et al. [8] suggested that when guidance
was provided on when to withhold or initiate anti-
biotic treatment based on specific cut-off values, the
effect of POC CRP was more prominent [12–15]. Up to
now, such cut-offs in children are lacking.
In the original ERNIE2 trial, we have shown that
POC CRP without guidance did not reduce antibiotic
prescribing in children with acute non-severe infec-
tions in primary care in comparison to usual care [10].
For the present paper, we tested whether family
physicians (FP) take CRP into account once measured
and to what extent this influences their adherence to
the guidelines (Figure 1).
Our hypothesis was that normal CRP levels would
support FPs to follow the EBM practice guidelines
when the latter advise to withhold antibiotics.
Methodology
Study design
We performed an in-depth analysis of the ERNIE2 trial,
a cluster randomized controlled trial in children pre-
senting with an acute infection to a FP. Both the study
protocol and main results of the ERNIE2 trial have
been reported previously [10,16–19].
Study population
Participating family physicians
All FPs in Flanders (Belgium) prepared to consecutively
recruit at least five ill children during the inclusion
period, were eligible to participate. Details of the
recruitment procedure can be found in the published
study protocols [16,19].
Participating children
Children aged 1 month to 16 years presenting to a
participating FP with an acute infection of maximum 5
days were consecutively recruited and received an
intervention according to FP’s intervention group.
Children at risk for serious infection were identified by
means of a clinical prediction rule [17,20] based on
four clinical criteria, namely clinician concern (gut feel-
ing ‘something is wrong’), dyspnea, temperature
40 C, and diarrhea in children aged 1 to 2.5 years.
Children referred to secondary care were excluded.
Other exclusion criteria were episodes caused by
merely traumatic or neurological conditions, intoxica-
tion, psychiatric or behavioral problems or an exacer-
bation of a known chronic condition. Written informed
consent was solicited from the child’s accompanying
parent or legal guardian.
Intervention
In the ERNIE2 trial, a POC CRP test was performed in
(1) half of the children with acute non-severe infec-
tions (scoring ‘no’ on the four criteria of the clinical
prediction rule, random allocation of practices to per-
form POC CRP or not) and (2) all children at risk for
serious infection (scoring ‘yes’ (or ‘I don’t know’ in
case of clinician concern) on at least one of the criteria
of clinical prediction rule). For the present analysis, we
compared antibiotic prescribing in children in which
CRP was tested to those in which CRP was not tested.
For the POC CRP test (Afinion AS100 Analyzer,
Alere, USA), a finger prick was performed and the
result was available within 4minutes [21]. Guidance
on the interpretation of CRP-results was not provided,
as reliable cut-off values for children in primary care
are unknown [11].
Data collection
FPs registered child characteristics, clinical parameters,
preliminary diagnosis and treatment actions (or
EBM pracce guideline advice immediate anbioc prescribing
?
point-of-care CRP
Figure 1. Study rationale.
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referral) on a registration form. Parents completed a
diary until they deemed their child to be recov-
ered [16].
End points
The main outcome was the immediate antibiotic pre-
scribing rate. An immediate prescription is meant to
be delivered and administered immediately after the
consultation.
Sample size calculation
The original cluster randomized trial was sufficiently
powered [10]. Since post hoc power calculations are
not useful [22], we did not perform another sample
size calculation.
Statistical analysis
The analyses were performed with SPSS 24 [23]. We
performed a mixed effects logistic regression analysis,
considering the hierarchical structure of the data
(practice level, FP level, patient level).
First, we investigated whether performing POC CRP
in itself would influence FP’s adherence to the guide-
lines. Secondly, we investigated whether this influence
was dependent on the CRP level (normal ver-
sus elevated).
Determining antibiotic prescribing advice provided
by the EBM practice guidelines
To determine whether antibiotics were prescribed
appropriately, we combined three different elements:
(1) preliminary diagnosis (e.g. acute otitis media), (2)
clinical signs (e.g. bulging tympanic membrane) and
(3) indicators for rational prescribing of antibiotics for
a specific diagnosis, following the Belgian national
guidelines (e.g. “fever lasting for 3 days or more in
children older than 24 months” in case of acute otitis
media) (Appendix 1). All diagnoses in which an anti-
biotic prescription could be recommended by the
Belgian Antibiotic Policy Coordination Committee
(BAPCOC) were considered, including acute tonsillitis,
acute otitis media, acute sinusitis, acute bronchitis,
pneumonia, pertussis, impetigo, erysipelas/cellulitis,
urinary tract infections and dysentery. The Belgian
guidelines [7] are consistent with the European guide-
lines but adapted to the Belgian bacterial resistance
patterns in the choice for an antibiotic class
and dosage.
Following this strategy, illness episodes were cate-
gorized in three distinct EBM practice guideline advice
groups, namely:
a. Prescribe antibiotic (e.g. acute otitis media in chil-
dren younger than 6 months)
b. Withhold antibiotic (e.g. acute otitis media in a
child older than 24 months without fever)
c. No advice, when (1) clinical signs or required indi-
cators were inconclusive, (2) when the FP
expressed doubt about the preliminary diagnosis
and (3) in case no the preliminary diagnosis
was registered.
Determining a valuable CRP cut-off
We used the cut-off of 5mg/L to dichotomize our
results to “normal” versus “elevated”.
Besides performing POC CRP and adherence to
EBM practice guideline advice, we added 3 covariates
to our model to adjust for expected confounding due
to the design of the original ERNIE2 trial. Practice type
was added because we performed stratification at this
level. The result on the clinical prediction rule was
added since (1) FPs knew that this rule identified chil-
dren at risk for serious infection (as shown before by
Van den Bruel et al. [20]) and (2) all these children
received a POC CRP test. The communicative interven-
tion of the original ERNIE2 trial (applying a brief inter-
vention to elicit parental concern combined with
safety net advice (BISNA), performed by half of the
FPs) was added considering this intervention increased
antibiotic prescribing [10].
After performing the partially adjusted analysis, we
adjusted our analyses further for other covariates that
could have influenced antibiotic prescribing too.
At practice level, we considered geographical region
(urban/rural).
At FP level, we investigated the role of personal
characteristics (FP’s gender, age, years of experience),
annual antibiotic prescription rate as provided by the
Quality assurance initiative of the Belgian social
security authority (RIZIV-INAMI) and an indicator of the
risk-avoiding attitude. We used the individual annual
antibiotic prescription rate during 2011 (proportion of
patients allocated to a FP who got an antibiotic pre-
scription during that year, children and adults, most
recent Belgian data available) as a proxy for baseline
antibiotic prescribing. National prescribing data for
children only were not available. We categorized FPs
as high or low prescribers (with the national mean as
threshold). As prescription data from early career FPs
and residents were not yet available, we considered
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them as a separate group. All FPs completed a vali-
dated questionnaire (5 questions) measuring their risk-
avoiding behavior (also called ‘defensive attitude’). The
higher the sum score of this questionnaire (range 5 to
25), the more the FP will prefer the certain to the
uncertain [24].
At child level, we considered age (infant, preschool
child, child/adolescent) and fever (no fever, elevation,
high fever (39 C or more)). We also considered the
perceived parental expectation regarding antibiotics,
which was registered by the FPs at the end of the
consultation by answering “yes/no” to the question:
“Do you think this parent expects antibiotic
treatment?”. The option “I don’t know” or missing val-
ues were categorized as “unknown”.
First, we explored which of these covariates at the
univariate level influenced immediate antibiotic pre-
scribing when added to the partially adjusted analysis.
Secondly, covariates with p-values lower than 0.1 were
included in the fully adjusted analysis, in addition to
the covariates for which limited imbalances between
the intervention groups were found: the child’s age
and temperature.
Results
Participant flow, recruitment and
numbers analyzed
169 FPs started recruitment. Initially, 3288 acute infec-
tious episodes were included between 15 February
2013 and 28 February 2014. After the application of
the exclusion criteria (Figure 2), 2844 acute infectious
episodes registered by 133 FPs (79 practices) were
analyzed. 34 physicians were excluded because they
included less than 5 children. Their baseline character-
istics were comparable to those of included FPs
(Appendix 2). 223 episodes were discarded because of
missing data on antibiotic prescribing. These children
were of similar age but had less often fever (p< .001)
and represented more cases in which no guideline
advice could be provided (p< .001) in comparison to
169 family physicians enrolled 3288 acute infectious episodes in children
221 infectious 
episodes 
excluded due to 
violation of the 
study protocol 
(47 no informed 
consent, 11 
known chronic 
condition, 83 no 
consecutive 
inclusion, 80 
referred to 
hospital by FP) 
223 infectious 
episodes 
excluded due to 
incomplete 
outcome data 
about antibiotic 
prescribing
CRP tested 
1719 infectious episodes, 
including: 
1178 non-severe acute infections 
(68.5%) 
541 illness episodes at risk for 
serious infection (31.5%) 
CRP not tested 
1125 infectious episodes, 
including: 
1049 non-severe acute infections 
(93.2%) 
76 illness episodes at risk for 
serious infection (6.8%) 
Figure 2. Flow chart representing the number of acute infectious episodes included in the study.
426 M. B. LEMIENGRE ET AL.
children of whom outcome data on antibiotic prescrib-
ing was available (Appendix 3). Illness episodes in
which performing POC CRP failed (no registered CRP
value) were added to the ’CRP not tested’ group.
Baseline characteristics
Family physicians
55 FPs (41.4%) were men. The mean age was 39.9
(standard deviation (SD) 10.7) and 17.3% were in post-
graduate training. Forty percent were practicing in an
urban region. The mean risk-avoiding behavior was 17.3
(SD 3.0 on a scale of 5 to 25), and the mean annual anti-
biotic prescription rate was 42.1% (SD 9.5). The median
number of included infectious episodes per FP was 14
(interquartile range (IQR) 8 to 23.5, range 3 to 342).
Children
Fifty-two percent of infectious episodes concerned
boys. The mean age was 4.6 years (SD 4.2, IQR 1.4 to
6.8; 34.0% infant, 37.9% preschool child, 28.2% child/
teenager). 37.5% suffered from high fever (39 C or
more). The top 3 preliminary diagnoses were: upper
respiratory tract infection (31.0%), acute otitis media
(15.3%) and other viral disease (11.1%) (Appendix 3).
617 children (21.6%) were at risk for serious infection
(according to the clinical prediction rule). As expected,
there were imbalances in age, temperature and the
presence of an appropriate indication for antibiotics
between children in which CRP was tested or not
tested (Appendix 4). This could be largely explained by
the fact that all children at risk for serious infection
according to the clinical prediction rule received a POC
CRP test and were therefore assigned to the ’CRP
tested’ group. Children at risk for serious infection were
generally younger, had more frequently high fever and
suffered more from bronchitis and pneumonia, which
was consequently reflected in the higher number of
episodes in which antibiotics were advised by the EBM
practice guidelines (Appendix 5). In children with acute
non-severe infections, some small imbalances in age
and fever between the study arms remained, but there
was no longer a difference in the number of illness
episodes in which EBM practice guidelines advised to
prescribe antibiotics (Appendix 5).
For 1287 episodes (45.3%), the parents returned the
diary. There were no differences in baseline character-
istics of children whose parents did or did not return
the diary, except a minor difference in the child’s tem-
perature: the number of children with high fever was
slightly larger when the diary was returned (39.2% ver-
sus 36.1%).
Outcomes and estimates
In 1719 illness episodes (59.6%), CRP levels were meas-
ured. CRP levels were normal in 693 illness episodes
(40.3%). Elevated CRP levels varied from 5 to 201mg/L
(mean 30.3 (SD 32.3), IQR 9-38). CRP was more fre-
quently elevated when the EBM practice guidelines
advised to prescribe antibiotics in comparison to those
episodes in which they advised to withhold antibiotics
(77.6% versus 52.9%, p< .001).
In 561 episodes (19.7%), FPs prescribed antibiotics
immediately. In 2410 illness episodes (84.7%), the col-
lected data provided enough information to determine
the antibiotic prescribing advice based on the EBM
practice guidelines. In 2013 illness episodes (83.5%), FPs
followed the antibiotic prescribing advice. In 175 illness
episodes (7.3%), overprescribing was detected. In 222
illness episodes (9.2%), under-prescribing was detected:
FPs withheld antibiotics when the EBM practice guide-
lines advised to prescribe immediately (Table 1).
The intracluster correlation coefficient (ICC) was low
(8.9% at practice level and 1.9% at FP level).
The partially and fully adjusted mixed logistic
regression analysis showed that performing POC CRP
in itself influenced adherence to the guideline: when
the EBM practice guidelines advise to prescribe antibi-
otics (A), mere performing of POC CRP (regardless of
the result) reduced prescribing (partially adjusted ana-
lysis: odds ratio (OR) 0.52 (95% Confidence Interval (CI)
0.32–0.84); fully adjusted analysis: adjusted odds ratio
(aOR) 0.54 (95% CI 0.33–0.90)). This was not the case
when EBM practice guidelines advise to withhold anti-
biotics (B) (partially adjusted analysis: OR 0.86 (95% CI
Table 1. Observed immediate antibiotic prescribing rates differ depending on (1) performance and/or result of POC CRP test
and (2) EBM practice guideline advice.
POC CRP test
CRP not tested Normal CRP level (<5mg/L) Elevated CRP level (5mg/L) Total
Advice
Prescribe antibiotic 88/149 (59.1%) 24/74 (32.3%) 146/257 (56.8%) 258/480 (53.6%)
Withhold antibiotic 71/824 (8.6%) 17/521 (3.2%) 87/585 (14.9%) 175/1930 (9.1%)
No advice 44/152 (28.9%) 9/98 (9.2%) 75/184 (40.7%) 128/434 (29.4%)
Total 203/1125 (18.0%) 50/693 (7.2%) 308/1026 (30.0%) 561/2844 (19.7%)
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0.58–1.27); fully adjusted analysis: aOR 0.81 (95%
CI 0.54–1.20)).
Focusing on the result of the POC CRP test (normal
or elevated), the partially adjusted and fully adjusted
mixed logistic regression analysis showed that normal
CRP levels further reduced antibiotic prescribing what-
ever EBM practice guidelines advise (fully adjusted ana-
lysis: “prescribe antibiotics (A)”: aOR 0.24 (95% CI
0.11–0.50); “withhold antibiotics (B)”: aOR 0.31 (95% CI
0.17–0.57); “no advice (C)”: aOR 0.26 (95% CI 0.11–0.64)).
Elevated CRP levels did not significantly increase pre-
scribing, except when no advice (C) could be given
because the preliminary diagnosis and/or clinical indica-
tors were lacking or unsure (borderline significance)
(fully adjusted analysis: “no advice (C)”: aOR 1.82 (95%
CI 1.01–3.27)) (Figure 3, Table 2, Appendix 6).
Sensitivity analyses for children with acute non-
severe infections versus children at risk for serious
infections (according to the clinical prediction rule),
followed the same trend (Appendix 7 and 8).
Harms
All children recovered. Based on data from the diaries, on
average, children were better in 4 days (SD 3.9, IQR
2.0–5.0). 7 children (0.3%) were hospitalized for a serious
infection. All these children were identified by the clinical
prediction rule as at risk for serious infection and no hos-
pitalization was due to unjustly withholding antibiotics.
Discussion
Main findings
Although the use of POC CRP without guidance did not
reduce immediate antibiotic prescribing [10], FPs clearly
consider CRP once available: independent of what
guidelines advise, normal CRP levels are a strong argu-
ment for FPs to withhold antibiotics. POC CRP discour-
ages antibiotic prescribing even when EBM practice
guidelines advise the opposite. This finding is extraor-
dinary, since there is at this moment still no evidence
that CRP can reliably discriminate viral from bacterial
infections in acute infections in children [25–27].
Strengths and limitations
Our databank consists of a large unique collection of
illness episodes representative for infections com-
monly seen in children by FPs. The registered clinical
Figure 3. Estimated marginal means of the immediate antibiotic prescribing rate (with 95% confidence interval) according to EBM
guideline advice and POC CRP testing (partially adjusted analysis). EBM: Evidence Based Medicine; POC CRP: point-of-care C-react-
ive protein.
Table 2. Influence of POC CRP (normal or elevated versus not
measured) on immediate antibiotic prescribing according to
EBM guideline advice.
Partially
adjusted analysisb
Fully
adjusted analysisc
OR 95%CI OR 95%CI
Advice: “Prescribe antibiotic (A)” (480 illness episodes)
Normal CRP level 0.23 0.12–0.45 0.24 0.11–0.50
Elevated CRP level 0.67 0.41–1.11 0.69 0.40–1.17
CRP not testeda
Advice: “Withhold antibiotic (B)” (1930 illness episodes)
Normal CRP level 0.28 0.16–0.51 0.31 0.17–0.57
Elevated CRP level 1.43 0.95–2.15 1.23 0.80–1.89
CRP not testeda
No advice (C) (434 illness episodes)
Normal CRP level 0.22 0.10–0.50 0.26 0.11–0.64
Elevated CRP level 1.73 1.01–2.96 1.82 1.01–3.27
CRP not testeda
aReference category.
b2844 illness episodes analyzed. Adjusted for performance of the BISNA-
intervention, risk for serious infection estimated by a clinical prediction
rule, practice type.
c2804 illness episodes analyzed (40 episodes (1.4%) excluded because
missing information about temperature). Adjusted for applying the
BISNA-intervention, risk for serious infection estimated by a clinical pre-
diction rule, practice type, region, mean annual antibiotic prescription
rate, perceived parental expectation regarding antibiotics, child’s age,
temperature.
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data provided sufficient information to formulate a
guideline based antibiotic prescribing advice in 85%
of illness episodes, which makes our results solid.
The observed antibiotic prescribing rate was low
(31.9%, of which 19.7% immediate prescriptions).
Based on data from a Belgian continuous and inte-
grated computerized morbidity registration network
(INTEGO) [28], we expected a prescribing rate of 40%.
FPs may have inclined to avoid prescribing antibiotics
during the trial because they were eager to perform
well [29]. The low prescribing rate in our study cannot
be explained by the selection of FPs since their mean
annual antibiotic prescription rate was comparable to
the national mean. Moreover, 31.2% of the immediate
prescriptions could still be considered as inappropriate
which highlights the room for improvement.
The Belgian BAPCOC guidelines [7] formed the
basis to assess the EBM practice guideline advice,
since these are the ones that should be followed by
the participating FPs. These guidelines are consistent
with the European guidelines but adapted to the
Belgian bacterial resistance patterns. In comparison to
the US guidelines, these recommendations are more
restrictive in indications for antibiotic treatment for
acute otitis media (considering age, clinical signs, risk
factors for complications or severe illness) and pharyn-
gitis (no common practice to test for streptococcus A
infection) [30,31].
The assessment of the EBM practice guideline
advice was done following strict predetermined rules
but was inevitably dependent on the quality of the
registered information. The preliminary diagnoses reg-
istered by the FP, were classified independently by
two investigators to avoid imprecision bias in coding.
Moreover, our strategy dealt effectively with the risk
of ‘diagnostic labeling’ (when FPs register a specific
preliminary diagnosis to justify their antibiotic pre-
scription) since a diagnostic label was not sufficient to
decide whether there was an appropriate indication
for antibiotics. For the analyses we separated illness
episodes in which there was insufficient information
to reconstruct any advice.
In 10.9% (310/2844) of the infectious episodes, FPs
thought that parents expected antibiotics. Although
we did not find a significant difference concerning
this covariate between infectious episodes with known
and unknown CRP levels (10.9% (188/1719) versus
10.8% (122/1125), p¼ .71), the analyses were corrected
for this covariate because it is known that the per-
ceived expectation strongly influences antibiotic pre-
scribing [32–35]. We aimed to estimate the effect of
knowing CRP levels on antibiotic prescribing,
independent of the influence of the perceived paren-
tal expectation for antibiotics.
We used the threshold of 5mg/L to dichotomize
the results of the POC CRP test (normal versus ele-
vated). Previously, the ERNIE2 trial showed that
when adding a POC CRP test to a clinical prediction
rule, this threshold was useful to further exclude ser-
ious illness in primary care [17,18]. For other pro-
posed thresholds, varying from 10 to 50mg/L, there
is no good evidence in primary care that these are
useful to exclude serious illness, nor to differentiate
between viral and bacterial disease [11]. Our trial
did not have enough power to examine subgroups
based on different thresholds.
Because of the original trial design in which all chil-
dren at risk for serious infection had a POC CRP test,
the group of children with known CRP levels was
somewhat different from the group of children in
which CRP was not tested. Still, adjusting for these
imbalances and performing sensitivity analyses for
children at low versus higher risk for serious infection
did not change our overall result.
Systematic POC CRP testing was performed in
half of the children according to the protocol of the
ERNIE2-trial in order to answer its divergent research
questions [16,19]. This practice does not replicate
clinical work in primary care. In case of no uncer-
tainty, physicians have no need to use additional
testing and should be able to reassure parents with-
out antibiotic prescription. Furthermore, introducing
systematic POC CRP testing could lead to high cost
for the health insurance: (1) the device as the test
kits are expensive, and (2) when the CRP level is
not congruent with the FP’s clinical appraisal, this
can further lead to unnecessary additional testing
and referrals.
Our results are generalizable to similar children in
other developed countries. However, results could be
different in countries with lower health care
accessibility.
Comparison with existing literature
We did not find any trials investigating the effect of
using POC CRP on the adherence to the antibiotic pre-
scribing guidelines. Other trials investigating the
adherence to guidelines, focused on the relation
between a prescription and a certain diagnosis
[36–41], but not on the effect of the introduction of
new technology on guideline adherence.
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Implications for research and/or practice
FPs tend to withhold antibiotics for acute infections
with normal CRP levels, even when EBM practice
guidelines advice to prescribe. In our trial, we have no
arguments to state that this finding is caused by
guideline unawareness, since the adherence of partici-
pating FPs to these guidelines was remarkably high
(83.5%). The finding that POC CRP discourages anti-
biotic prescribing when EBM practice guidelines advise
differently, gives a cause for concern as it may result
in under-prescribing and could be dangerous, since a
normal CRP during the doctors’ visit is no guarantee
for an uncomplicated illness course. However, in our
trial, all children recovered, and no hospitalization for
serious infection could be attributed to under-prescrib-
ing. EBM guidelines are vague at some points.
Probably, normal CRP levels tipped the scale to with-
hold antibiotics in illness episodes in which the EBM
practice guideline advice leaves too much room for
doubt. We hypothesize that a normal CRP offered FPs
a convincing argument to withhold antibiotic in those
illness episodes where advice to prescribe antibiotics
went against their own gut feeling.
Evidence based guidelines should form the basis
for the clinical decision making. However, in this in-
depth analysis, we found that FPs seem to be recep-
tive for a tangible argument such as POC CRP. Up to
now, POC CRP was never explored to narrow the
safety margins of the guidelines or make the instruc-
tions more clear-cut. Future research should focus on
whether POC CRP can effectively help to more accur-
ately identify children who might benefit from antibi-
otics without increasing the risks of under-prescribing.
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Appendix 1: Rational indications for antibiotics according to the Belgian guidelines (BAPCOC)
Appendix 2: Comparison of characteristics of included and excluded FP (after randomization)
Preliminary diagnosis Required clinical symptom Required criteria for rational prescribing
Acute tonsillitis Pus on tonsils Appearing seriously ill or less eating/drinking
Acute otitis media Clinical signs of acute otitis media 1.< 6 months
OR
2. 6–24 months and appearing seriously ill, fever
lasting at least 2 days or bilateral AOM
OR
3. >24 months and persistent fever lasting at least
3 days or appearing seriously ill
OR
4. Persistent otorrhea
Acute sinusitis No clinical symptom required 1. Appearing seriously ill
OR
2. Fever 39 C
OR
3. Red swollen face or eyelid (referral)
Pneumonia No clinical symptom required No criteria required
Acute bronchitis No clinical symptom required 1.< 3 months (referral)
OR
2.< 24 months and insufficient fluid intake or
breathing rate >70/’ (referral)
OR
3. Suspected for serious infection (insufficient fluid
intake and vomiting, breathing rate >50/’, oxy-
gen saturation 92%, sleepy, waking up hard,
irritable, drowsy, reduced consciousness, moan-
ing, nasal flaring or chest wall retract-
ing) (referral)
Pertussis No clinical symptom required No criteria required
Impetigo No clinical symptom required Fever 38.5 C, adenopathy or failure
local therapy
Erysipelas No clinical symptom required No criteria required
Urinary tract infection (cystitis or pyelonephritis) No clinical symptom required No criteria required
Gastrointestinal infection with diarrhea Diarrhea Fever 38.5 C, bloody diarrhea or appearing ser-
iously ill
BAPCOC: Belgian Antibiotic Policy Coordination Committee.
Characteristic
Included FP (133) Excluded FP (34)
pn (%) / mean (SD) n (%) / mean (SD)
Gender (man) 55 (41.4%) 14 (41.2%) .991
Age 39.9 (10.7) 38.7 (13.2) .572
Region (urban) 53 (39.8%) 8 (25.0%) .181
Graduated (resident) 23 (17.3%) 7 (21.2%) .601
Years of experience 13.3 (10.8) 12.3 (13.0) .662
Practice type (exclusive residents) .141
 Solo 19 (14.3%) 8 (23.5%)
 Duo 45 (33.8%) 6 (17.6%)
 Group 69 (51.9%) 20 (58.8%)
1Chi-square test
2Student t test
FP: family physician; SD: standard deviation.
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Appendix 3: Comparison of characteristics of infectious episodes with and without outcome data
Appendix 4: Comparison of characteristics of infectious episodes with tested CRP versus those in
which CRP was not tested
Characteristic
Included infectious episode (2844) Excluded infectious episodes (223)
pn (%) n (%)
Age$
Infant 966 (34.0%) 69 (31.5%) .16
Preschool child 1077 (37.9%) 75 (34.2%)
Child 801 (28.2%) 75 (34.2%)
Temperature$
No fever 626 (22.3%) 76 (36.5%) <.001
Elevation 1127 (40.3%) 76 (36.5%)
High fever (39 or more) 1051 (37.5%) 56 (26.9%)
CRP
Tested 1719 (60.4%) 129 (57.8%) .45
Not tested 1125 (39.6%) 94 (42.2%)
EBM guideline advice
Prescribe antibiotic (A) 480 (16.9%) 8 (3.6%) <.001
Withhold antibiotic (B) 1930 (67.9%) 151 (67.7%)
No advice (C) 434 (15.3%) 64 (28.7%)
$4 cases no information about age (4 excluded infectious episodes), 55 cases no information about temperature
(40 included infectious episodes, 15 excluded infectious episodes).
Characteristic
CRP tested (1719) CRP not tested (1125)
pn (%) (%)
Age
Infant 581 (33.8%) 385 (34.2%) .002
Preschool child 615 (35.8%) 462 (41.1%)
Child 523 (30.4%) 278 (24.7%)
Temperature$
No fever 400 (23.3%) 226 (20.1%) .001
Elevation 634 (36.9%) 493 (43.8%)
High fever (39 or more) 664 (38.6%) 387 (34.4%)
EBM guideline advice
Prescribe antibiotic (A) 331 (19.3%) 149 (13.2%) <.001
Withhold antibiotic (B) 1106 (64.3%) 824 (73.2%)
No advice (C) 282 (16.4%) 152 (13.5%)
Top 10 preliminary diagnoses
Upper respiratory tract infection, acute 482 (28.0%) 401 (35.6%) NA
Acute otitis media 276 (16.1%) 158 (14.0%)
Viral disease, other (NOS) 197 (11.5%) 119 (10.6%)
Gastroenteritis, presumed infection 160 (9.3%) 93 (8.3%)
Bronchitis (no bronchiolitis) 183 (10.6%) 67 (6.0%)
Tonsillitis 119 (6.9%) 96 (8.5%)
Influenza 111 (6.5%) 56 (5.0%)
Pneumonia 67 (3.9%) 15 (1.3%)
Urinary tract infection 42 (2.4%) 15 (1.3%)
Bronchiolitis 23 (1.3%) 9 (0.8%)
No preliminary diagnosis registered 103 (6.0%) 63 (5.6%)
Diary return 777 (45.2%) 510 (45.3%) .945
$40 infectious episodes were excluded because of missing information about temperature.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 433
Appendix 5: Comparison of characteristics of infectious episodes with tested CRP versus those in
which CRP was not tested, according to the risk for serious infection
Appendix 6: Influence of POC CRP (normal or elevated versus not tested) on immediate
antibiotic prescribing depending on EBM guideline advice (final adjusted analysis,
complete model)
Non-severe acute infections
Illness episodes at risk for
serious infection
Characteristic
CRP tested CRP not tested CRP tested CRP not tested
(1178) (1049) (541) (76)
Age
Infant 330 (28.0%) 351 (33.5%) 251 (46.4%) 34 (44.7%)
Preschool child 404 (34.3%) 431 (41.1%) 211 (39.0%) 31 (40.8%)
Child 444 (37.7%) 267 (25.5%) 79 (14.6%) 11 (14.5%)
Temperature$
No fever 349 (30.1%) 219 (21.2%) 51 (9.5%) 7 (9.5%)
Elevation 495 (42.7%) 473 (45.8%) 139 (25.8%) 20 (27.0%)
High fever (39 or more) 315 (27.2%) 340 (32.9%) 349 (64.7%) 47 (63.5%)
EBM guideline advice
Prescribe antibiotic (A) 161 (13.7%) 130 (12.4%) 170 (31.4%) 19 (25.0%)
Withhold antibiotic (B) 850 (72.2%) 788 (75.1%) 256 (47.3%) 36 (47.4%)
No advice (C) 167 (14.2%) 131 (12.5%) 115 (21.3%) 21 (27.6%)
Top 10 preliminary diagnoses
Upper respiratory tract infection, acute 384 (32.6%) 383 (36.5%) 98 (18.1%) 18 (23.7%)
Acute otitis media 193 (16.4%) 152 (14.5%) 83 (15.3%) 6 (7.9%)
Viral disease, other (NOS) 147 (12.5%) 115 (11.0%) 50 (9.2%) 4 (5.3%)
Gastroenteritis, presumed infection 101 (8.6%) 80 (7.6%) 59 (10.9%) 13 (17.1%)
Bronchitis (no bronchiolitis) 89 (7.6%) 60 (5.7%) 94 (17.4%) 7 (9.3%)
Tonsillitis 84 (7.1%) 88 (8.4%) 35 (6.5%) 8 (10.5%)
Influenza 84 (7.1%) 50 (4.8%) 27 (5.0%) 6 (7.9%)
Pneumonia 18 (1.5%) 9 (0.9%) 49 (9.1%) 6 (7.9%)
Urinary tract infection 22 (1.9%) 11 (1.0%) 20 (3.7%) 4 (5.3%)
Bronchiolitis 5 (0.4%) 8 (0.8%) 18 (3.3%) 1 (1.3%)
No preliminary diagnosis registered 50 (4.2%) 54 (5.3%) 53 (9.8%) 9 (11.8%)
$40 infectious episodes were excluded because of missing information about temperature (36 in children with non-serious acute
infections, 4 in children at risk for serious infection).
Fully adjusted analysis$
OR 95%CI
Advice: “Prescribe antibiotic (A)” (480 illness episodes)
Normal CRP level 0.24 0.11–0.50
Elevated CRP level 0.69 0.40–1.17
CRP not tested
Advice: “Withhold antibiotic (B)” (1930 illness episodes)
Normal CRP level 0.31 0.17–0.57
Elevated CRP level 1.23 0.80–1.89
CRP not tested
No advice (C) (434 illness episodes)
Normal CRP level 0.26 0.11–0.64
Elevated CRP level 1.82 1.01–3.27
CRP not tested
Practice type
Group 1.22 0.76–1.97
Duo 0.88 0.54–1.42
Solo
Clinical prediction rule
Children at risk for serious infection 2.08 1.54–2.81
Children with non-severe acute infections
BISNA
BISNA performed 1.29 0.91–1.83
BISNA not performed
(continued)
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Appendix 7: Influence of POC CRP (normal or elevated versus not tested) on immediate
antibiotic prescribing depending on guideline advice in children with non-severe
acute infections
Continued.
Fully adjusted analysis$
OR 95%CI
Region
Urban 0.95 0.66–1.37
Rural
Mean annual antibiotic prescription rate
Resident/Early career FP 1.78 1.12–2.82
High prescriber 2.21 1.48–3.31
Low prescriber
Perceived parental expectation regarding antibiotics
Unknown 2.70 1.95–3.73
Present 12.10 8.60–17.00
Absent
Child’s age
Infant 0.72 0.51–1.01
Preschool 0.99 0.72–1.36
Child/Adolescent
Temperature
High fever 2.09 1.37–3.19
Elevation 1.58 1.05–2.37
No fever
Reference category.
$40 infectious episodes were excluded because of missing information about temperature.
Partially adjusted analysis$1 Fully adjusted analysis$2
OR 95%CI OR 95%CI
Advice: “Prescribe antibiotic (A)” (291 illness episodes)
Normal CRP level 0.28 0.12–0.64 0.27 0.11–0.66
Elevated CRP level 0.55 0.29–1.01 0.65 0.34–1.25
CRP not tested
Advice: “Withhold antibiotic (B)” (1638 illness episodes)
Normal CRP level 0.26 0.13–0.54 0.28 0.13–0.60
Elevated CRP level 1.58 0.95–2.63 1.44 0.86–2.40
CRP not tested
No advice (C) (298 illness episodes)
Normal CRP level 0.11 0.03–0.40 0.14 0.04–0.56
Elevated CRP level 1.28 0.64–2.57 1.38 0.65–2.92
CRP not tested
Reference category
$12227 illness episodes analyzed. Adjusted for performance of the BISNA-intervention, risk for serious infection esti-
mated by a clinical prediction rule, practice type.
$22191 illness episodes analyzed (36 episodes (1.6%) excluded because missing information about temperature).
Adjusted for performance of the BISNA-intervention, practice type, region, mean annual antibiotic prescription rate,
perceived parental expectation regarding antibiotics, child’s age, temperature.
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Appendix 8: Influence of POC CRP (normal or elevated versus not tested) on immediate
antibiotic prescribing depending on guideline advice in children at risk for serious infection
Partially adjusted analysis$1 Fully adjusted analysis$2
OR 95%CI OR 95%CI
Advice: “Prescribe antibiotic (A)” (189 illness episodes)
Normal CRP level 0.25 0.07–0.93 0.46 0.11–1.92
Elevated CRP level 1.30 0.45–3.79 1.74 0.54–5.58
CRP not tested
Advice: “Withhold antibiotic (B)” (292 illness episodes)
Normal CRP level 0.25 0.07–0.86 0.32 0.09–1.14
Elevated CRP level 1.02 0.40–2.64 0.96 0.35–2.65
CRP not tested
No advice (C) (136 illness episodes)
Normal CRP level 0.50 0.13–1.91 0.45 0.10–1.98
Elevated CRP level 2.69 0.93–7.81 2.29 0.69–7.65
CRP not tested
Reference category
$1617 illness episodes analyzed. Adjusted for performance of the BISNA-intervention, risk for serious infection esti-
mated by a clinical prediction rule, practice type.
$2613 illness episodes analyzed (4 episodes (0.6%) excluded because missing information about temperature).
Adjusted for performance of the BISNA-intervention, practice type, region, mean annual antibiotic prescription
rate, perceived parental expectation regarding antibiotics, child’s age, temperature.
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